Stay informed on what’s happening in hematology! Brought to you by Editor-in-Chief Aaron Gerds, MD, webinars from ASH Clinical News cover relevant topics in hematology and provide an opportunity to participate in and learn from discussions with key speakers.
If you missed our most recent webinars, you can sign up to view the recordings by following the registration links below.
Drawing First Blood: Will Menin Inhibitors Revolutionize the Treatment of AML?
Menin inhibitors constitute a new genre of agents targeting the underlying biology of NPM1-mutant and KMT2A-rearranged acute leukemia by disrupting the interaction between the KMT2A and menin proteins, which then forces the leukemia cells to differentiate into normal cells. Preclincal studies and early clinical trials of menin inhibitors in the treatment of acute myeloid leukemia (AML) have shown strong results.
Because there are few targeted therapies for AML, the development of menin inhibitors and the resulting outcomes for patients are exciting, but a lot of unknowns still exist. In this Drawing First Blood webinar, experts Mikkael Sekeres, MD, MS, Laura Michaelis, MD, and Eytan Stein, MD, discuss many of the questions surrounding the development and use of menin inhibitors.
Click here for more information and to watch the recording!
Get Involved at ASH: Volunteer Opportunities
Learn more about the volunteer opportunities available at the American Society of Hematology (ASH) and how to become more involved! In this roundtable discussion, ASH members Michael L. Linenberger, MD; Maya Abdallah, MD; and Matthew L. Ulrickson, MD, join Dr. Gerds to discuss their experiences volunteering at ASH, how volunteering has contributed to their career growth and development, and how interested individuals can take that first step to volunteer. Click here for more information and to watch this lively discussion!
